SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-326190
Filing Date
2021-11-10
Accepted
2021-11-10 17:14:57
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d195327ds3.htm S-3 493524
2 EX-4.6 d195327dex46.htm EX-4.6 330277
3 EX-4.8 d195327dex48.htm EX-4.8 112633
4 EX-4.9 d195327dex49.htm EX-4.9 111667
5 EX-4.10 d195327dex410.htm EX-4.10 100055
6 EX-5.1 d195327dex51.htm EX-5.1 31069
7 EX-23.1 d195327dex231.htm EX-23.1 1681
8 GRAPHIC g195327cooleylogo.jpg GRAPHIC 3510
9 GRAPHIC g195327g06j65.jpg GRAPHIC 41652
10 GRAPHIC g195327g91n23.jpg GRAPHIC 41841
  Complete submission text file 0001193125-21-326190.txt   1302122
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-260970 | Film No.: 211397803
SIC: 2836 Biological Products, (No Diagnostic Substances)